{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dementia/goals-outcome-measures/audit-criteria/","result":{"pageContext":{"chapter":{"id":"a9c56eb4-bc0e-51cc-b486-a54c23906bc0","slug":"audit-criteria","fullItemName":"Audit criteria","depth":2,"htmlHeader":"<!-- begin field cd358b43-0632-44c7-9776-abf57b266817 --><h2>Audit criteria</h2><!-- end field cd358b43-0632-44c7-9776-abf57b266817 -->","summary":null,"htmlStringContent":"<!-- begin item bd6d7e10-229a-4e26-bea5-573d1517cdfd --><!-- begin field c34de8e0-b646-4baa-94bb-1dd5153f4c4c --><p>The National Institute for Health and Care Excellence (NICE) have developed a clinical audit tool that can be used to measure current practice in the support of people with dementia and their family/carers in health and social care against the recommendations in the NICE guideline <em>D</em><em>ementia: supporting people with dementia and their carers in health and social care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dementia/references/\">NICE, 2006</a>]. The full audit tool is available from the NICE website (<a href=\"https://www.nice.org.uk/\" data-hyperlink-id=\"f2c1b310-145d-4f2d-a506-a8f7014b73bb\">www.nice.org.uk</a>). </p><p><strong>Criterion 1</strong></p><ul><li>Percentage of people diagnosed with dementia where the health record shows evidence of continuing valid consent from the patient, or that the provisions of the Mental Capacity Act have been followed if the person lacks capacity.</li></ul><p><strong>Criterion 2</strong></p><ul><li>Percentage of carers who have been offered an assessment of needs as set out in the Carers and Disabled Children Act 2000 and the Carers (Equal Opportunities) Act 2004.</li></ul><p><strong>Criterion 3</strong></p><ul><li>Percentage of carers whose assessment of needs has established experience of psychological distress and negative psychological impact who have been offered psychological therapy, including cognitive behavioural therapy, by a specialist practitioner.</li></ul><p><strong>Criterion 4</strong></p><ul><li>There are jointly agreed, documented policies and procedures for dementia services, across local health and social care providers.</li></ul><p><strong>Criterion 5</strong></p><ul><li>Percentage of people with a possible diagnosis of dementia referred to memory assessment services.</li></ul><p><strong>Criterion 6</strong></p><ul><li>Percentage of people with dementia who are service users with a documented combined care plan where there is evidence that:<ul><li>The care plan has been agreed and, as appropriate, reviewed at an agreed frequency, to take account of any changing needs for the person with dementia or their carers</li><li>There is a named health and/or social care worker assigned to operate the plan</li><li>The care plan has been endorsed by the person with dementia and/or their carers.</li></ul></li></ul><p><strong>Criterion 7</strong></p><ul><li>Percentage of people with suspected dementia for whom structural imaging (computed tomography [CT] scanning or magnetic resonance imaging [MRI]) has been undertaken as part of assessment and diagnosis.</li></ul><p><strong>Criterion 8</strong></p><ul><li>Percentage of people with dementia who develop non-cognitive symptoms that cause significant distress to the individual or who develop behaviour that challenges, including agitation, for whom their care plan demonstrates that a comprehensive assessment has been undertaken to establish the likely causes and influences that may generate, aggravate, and improve the behaviour(s), covering:<ul><li>Physical health</li><li>Depression</li><li>Possible undetected pain or discomfort</li><li>Side effects of medication</li><li>Individual biography, including beliefs, spiritual and cultural identity</li><li>Psychosocial factors</li><li>Physical environmental factors</li><li>Specific behavioural and functional analysis conducted by trained professionals in conjunction with family carers and care workers.</li></ul></li><li>An individual care plan has been developed to help carers and staff to address the behaviour that challenges, and is documented in the notes.</li></ul><p><strong>Criterion 9</strong></p><ul><li>Dementia-care training is available for all staff working with older people in the health, social care, and voluntary sectors, appropriate to their different roles and responsibilities.</li></ul><!-- end field c34de8e0-b646-4baa-94bb-1dd5153f4c4c --><!-- end item bd6d7e10-229a-4e26-bea5-573d1517cdfd -->","topic":{"id":"de9cbb4d-2d69-500f-be27-dc83f76dc3ba","topicId":"2491e3e7-cc21-42b9-8972-e54804b4782f","topicName":"Dementia","slug":"dementia","lastRevised":"Last revised in October 2020","chapters":[{"id":"af834011-0042-530a-8f9a-acd5828e0a34","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a0360b83-4555-5079-897f-12b2d555c1af","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"52cd8e36-39cd-5259-8819-bd96087b0265","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"60bd6b27-027f-56a6-a018-a1d694a6a2f3","slug":"changes","fullItemName":"Changes"},{"id":"7ced1224-30c2-5f30-9caf-3764f3665ae4","slug":"update","fullItemName":"Update"}]},{"id":"fae05cff-ad98-52fa-89b4-b97369195d59","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2f3b4bd3-e7cf-5492-afe0-0a5b230eab7e","slug":"goals","fullItemName":"Goals"},{"id":"9104785e-e491-5ca3-b3d3-7e951385bce9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a9c56eb4-bc0e-51cc-b486-a54c23906bc0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebf62eba-a4cd-536c-8c9f-c9505b0e7482","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a71b8dc2-79f8-5d24-b668-c792abc5a624","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c87232ba-6926-5ff2-98d2-f8839b0c0d37","slug":"nice-quality-standards","fullItemName":"NICE Quality Standards"}]},{"id":"825c29c3-9d55-54ae-b54d-8ee2ac796e97","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"46c6316f-eec0-580a-80ec-2112d2f0122f","slug":"definition","fullItemName":"Definition"},{"id":"f485482d-0d4e-52cb-9df4-3548bc72a566","slug":"causes","fullItemName":"Causes"},{"id":"87101d89-6073-57cc-b247-48be586ef185","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"58f6ec5a-c90b-5e64-a476-fc9fca39c6ae","slug":"prevalence","fullItemName":"Prevalence"},{"id":"994469e3-f824-5f48-b755-7f74dd360680","slug":"prognosis","fullItemName":"Prognosis"},{"id":"718f9ed4-d725-5f6e-a86f-5df88719cd52","slug":"complications","fullItemName":"Complications"}]},{"id":"366bcbe3-827a-5e08-9d81-8de84e46fefd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"565bac2a-ada3-5b0a-ab7d-6681501b2c4a","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"4c0fe55f-40c9-5a1c-8cf3-1ec8d88406d5","slug":"assessment","fullItemName":"Assessment"},{"id":"ef7780bd-8e94-5f95-870f-92ab930c4365","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"3069f5e5-519f-50ec-81b7-c8948a5b3117","fullItemName":"Management","slug":"management","subChapters":[{"id":"c6c0cbc2-18fc-5bf8-973d-bc38b9001f28","slug":"suspected-dementia","fullItemName":"Scenario: Suspected dementia"},{"id":"6320a2da-e9d6-5f57-94d9-0433261edf89","slug":"follow-up-of-confirmed-dementia-in-primary-care","fullItemName":"Scenario: Follow up of confirmed dementia in primary care"},{"id":"343a59fa-439e-5ab9-9d3b-28a893d55d2f","slug":"management-of-end-stage-dementia","fullItemName":"Scenario: Management of end-stage dementia"}]},{"id":"9a2639de-07aa-5fe3-8f09-5c005f9c29dd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"58ed8441-e3ca-566e-9afb-92a5ba60b1dd","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"67092bd7-2ab4-5e8b-8ead-5301454da4a8","slug":"acetylcholinesterase-inhibitors","fullItemName":"Acetylcholinesterase inhibitors"},{"id":"f4ced652-a6de-5e19-ae37-6de43dfd8104","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"45d5f01b-c1c2-53dc-91b4-8f7a90983fd5","slug":"memantine-hydrochloride","fullItemName":"Memantine hydrochloride"}]},{"id":"1e87c908-2ab5-5cba-8d6a-958c03f7a6cd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fc7a2bcf-854b-5ca4-9b02-2dcaaebe1162","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7bcb26a3-cc69-5201-9fd9-6353e27b412f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c383917-58d0-5036-8217-5d9fd81cb2cb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fdb8af52-aeee-52bd-be79-c5534939d42f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a9f930f3-f8b6-5c8f-b8ca-b3155e0c23d3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"668c11fa-1873-58d4-b0e2-3eab90e8fbff","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"67c4aef9-fbf4-5bf6-8dc5-c501f74b1fe3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fae05cff-ad98-52fa-89b4-b97369195d59","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}